Web Seminar: Technology Showcase Webinar: Explore the latest Drug Delivery Advancements in Solid Dosage Forms through Glide's SDI® Delivery

Date: Wednesday, December 2, 2009
Time: 12:00 PM - 1:00 PM EST

Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/707185768
Mention priority code P1578W1TwitterBlog

Featured Speaker:
Charles Potter, CEO
Glide Pharma

About the Webinar:
Glide Pharma has developed the Glide SDI (Solid Dose Injector) for injecting drugs and vaccines in a solid dosage form, without the need for a needle. The technology offers many benefits, such as drug stability and controlled release, and is suitable for self-injection of drugs in a home environment. The Glide SDI is patent protected and in clinical trials has been preferred to an injection with a standard needle and syringe.

The seminar will give an overview of the Glide SDI, its benefits and pipeline of product opportunities. Data will be presented demonstrating the utility of the technology together with plans for the commercialization of the Glide SDI. In addition, an overview of the competitive landscape for injection technologies will be provided.

What you will learn:
• An introduction to the Glide Solid Dose Injector
• The benefits of injecting drugs in a solid dosage form
• The market opportunities for a differentiated drug delivery technology
• The competitive landscape for injection technologies

This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today on LinkedIn or Follow us on Twitter!

Share this article with your social network, just click below to share now!

Share |

Drug Delivery Partnerships 2010 agenda released!

The new program for Drug Delivery Partnerships (DDP) 2010 is now available. There are over 30 all new topics covering the hottest issues affecting your business NOW including:

• Healthcare Payment reform’s Potential Impacts on Payment, reimbursement and Innovation of Pharmaceuticals and Delivery Products
• Pharmaceutical, Biotech and Drug Delivery Investment Trends in the Current Economic Climate and Its Impact on Business Deals
• Understanding how Payers View and Manage the Medical
• Development of novel RNAi Compounds and Delivery Approaches
• Drug Delivery Opportunities in the Animal Health Market
• Maximize opportunities for Tomorrow - Tools for Evaluating and Negotiating in Emerging Markets
• Drug Delivery and Biosimilar Utilization
• Pipeline to Improve Product Value Calculations

Download the brochure here.

We look forward to seeing you Orlando!


This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today on LinkedIn!

Share this article with your social network, just click below to share now!

Share |

Self-administration drug delivery evolving the industry

According to zikkir, the future of drug delivery is increasingly turning towards self-administration. With medical advances, patients are increasingly able to give themselves their prescriptions. Because these devices that are already pre-filled and easier to use, they're leading to more patient compliance. Read more about the increase in self-administration drug delivery devices here.

What do you think? With the growing number of patient-administered drug delivery devices, do you think this will contribute to a patient's compliance to continually and regularly take their medication?


If you'd like to network with other professionals in the drug delivery field, join our LinkedIn group! Or follow us on Twitter at http://www.twitter.com/drugdeliveryiir!

Share this article with your social network, just click below to share now!

Share |

Illinois researchers have developed new cancer drug delivery method

University of Illinois researchers have developed a new drug delivery system to treat cancer. In trying to only kill tumor cells and allow the healthy cells to live, as well as allow the side effects of the procedure to be reversed in order to cut down the length of time for side effects. Read the full article here.


This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today on LinkedIn!

Share this article with your social network, just click below to share now!

Share |

The state of the art targeted delivery options for your macromolecule

Targeted macromolecular drugs have been touted as the treatment of the future for cancer and cardiovascular disease. To achieve this promise, safe and efficient drug delivery strategies must be realized. While formulation strategies have progressed significantly over the past several years, the industry still faces challenges in advancing delivery of biologics.

Join us in Boston this September 23-25 at the Biologics Drug Delivery & Beyond event, where you will uncover the latest technologies for effectively delivering your macromolecule, including a featured session entitled “The Magic Bullets of the Shots Heard Round the World: Targeted Macromolecule Delivery”, which provides insight on how to:

* Deliver biologics to target
* Use advanced drug delivery formulation for targeting
* Enable macromolecules targeting to treat

In addition, participants hear from David Cipolla of Aradigm on local and systemic lung delivery of peptides, oligos and proteins using solution inhalers. No other event brings the scientific leaders at the forefront of biologic drug delivery under one roof.

Visit our website for complete agenda details, as well as access to presentations from the 2009 Drug Delivery Partnerships event.

Join us on Twitter!

This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today!

Share this article with your social network, just click below to share now!

Share |

14th Annual Drug Delivery Partnerships Event Survey and Official Call for Presenters

14th Annual Drug Delivery Partnerships Event Survey and Official Call for Presenters
The 14th Annual Drug Delivery Partnerships event development is currently underway, and the planning committee wants to ensure that we develop an event which fully addresses your needs, concerns, and business opportunities.
First of all, please take the time to complete this short survey telling us what you want to learn and who you want to meet at next year's event-


Second, if you have first-hand perspectives, insights or case studies to share, your peers want to hear about it. Join the DDP 2010 speaking faculty to share your story and position your organization as a drug delivery leader.
We plan to focus on the following areas in 2010:

· Strategic Business Development Strategies
· Life Cycle Management & Product Development
· Partnering for Innovation & Forming R&D Alliances
· The Latest Innovative Drug Delivery Technology to Fuel Deals~
· Drug Device/Medical Device Products
· Venture Capital Perspective
· Globalization
· Patient Adherence

For consideration, please e-mail tcarle@iirusa.com or call 646 895-7341 with the following information no later than Friday, July 10th, 2009.

· Proposed speaker name(s), job title(s), and company name(s)
· Contact information including address, telephone and fax numbers and e-mail
· Title and objective of presentation
· Please indicate which of the topics you plan to address. If it is the latest tools and techniques please indicate what is NEW about them. (Please indicate the topic area if it is a workshop and indicate how you plan to create an interactive session)

· Summary of the talk
· What the audience will gain from your presentation (please list 3-5 key “take aways”)
*Sessions are 30-45 minutes including Q&A.
Speakers receive FREE admission to the conference as well as any pre-conference activity such as workshops or symposium.

The 14th Annual Drug Delivery Partnerships event has a limited number of slots available for solution providers/consultants/vendors. There are opportunities available for organizations to join the event by sponsoring or exhibiting. We tailor our sponsorships to the individual requirements of your unique organization. To find out how we can work with you to raise your profile and help you maximize business at this MUST-ATTEND event, contact Beth George at 415 945-9044, or email: bgeorge@iirusa.com. If you are interested in exhibiting, please contact Michael Vidoni at 646 895-7479, or email: mvidoni@iirusa.com.

Mention to them you heard about it through this LinkedIn group!

To learn more about the Drug Deliver Partnerships event visit our LinkedIn group and start networking today!

Share this article with your social network, just click below to share now!

Share |

Drug Delivery Partnerships Live from the Red Rock

It is with great pleasure that we launch IIR's Future of BioPharma blog live from the 13th Annual Drug Delivery Partnerships event at the Red Rock Resort and Spa in Las Vegas, NV.

The Executive Director, Tricia Carle opened DDP this morning and introduced the conference co-chair Dr. Peter Kramer, Executive Director of External Science & Technology, Strategic Transactions Group at Bristol Myers Squibb who remarked that we are at the cross roads of change and innovation in the Biopharmaceutical drug delivery industry. He then introduced Debra Bingham a partner at Valeo Partners who kicked us off with a Letterman style Top 10 list of the 2008 Events that will Impact in Drug Delivery in 2009.

10. Branded DD products go generic
9. Nektar sells inhalation business to Novartis for $115 million in October 2008
8. The dismantling of Alza - Acquired for $12 billion in 2001
7. Pfizer pulls Exubera from the market in 10/07 and Novo stops development
6. Pfizer reports lung cancer in study and Nektar discontinues Exubera partnering
5. 2008 Roche acquires Mirus for RNAi delivery for $125 million
4. Jan 27, 2006 inhaled insulin approved
3. Large restructuring of big pharma 2006- Present creating an entrepreneurial spirit
2. Mandate for healthcare policy change in U.S.
1. The current financial crisis

So what will the impact of these events be?

1. Regulatory pressures and changes (regulatory, pricing, generics, doctor relationship controls)
2. Increased financial pressure on CEOs and boards of emerging companies
3. Increased M& A activity
4. Pay and regulatory pressure to prove the benefit of rug delivery - What is the value proposition of our technology not just in extending patents but in increasing value for the end user and convincing third party payers that your product is worth reimbursing
5. Continued opportunity to enable delivery of difficult therapeutics

Stay tuned for more Drug Delivery updates live from the Red Rock! And be sure and sign up for our DDP LinkedIn group to continue networking with industry peers.

Share this article with your social network, just click below to share now!

Share |